Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification.

about

Urinary Markers in Bladder Cancer: An Update

P2860

Q58758892-1C0C884A-1102-417D-AD70-EC0E81ABBB67

P2860

Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification.

Item

http://www.wikidata.org/entity/Q55260461

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Exploring the roles of urinary ...... ognosis & risk stratification.

@en

Exploring the roles of urinary ...... ognosis & risk stratification.

@nl

type

Item

label

Exploring the roles of urinary ...... ognosis & risk stratification.

@en

Exploring the roles of urinary ...... ognosis & risk stratification.

@nl

prefLabel

Exploring the roles of urinary ...... ognosis & risk stratification.

@en

Exploring the roles of urinary ...... ognosis & risk stratification.

@nl

P1154

2-s2.0-85047225529

http://www.w3.org/2001/XMLSchema#string

P1433

Oncotarget

P1476

Exploring the roles of urinary ...... ognosis & risk stratification.

@en

P2093

Andrew J Sutton

http://www.w3.org/2001/XMLSchema#string

Douglas G Ward

http://www.w3.org/2001/XMLSchema#string

James C Goldsmith

http://www.w3.org/2001/XMLSchema#string

K K Cheng

http://www.w3.org/2001/XMLSchema#string

Naheema S Gordon

http://www.w3.org/2001/XMLSchema#string

Nicholas D James

http://www.w3.org/2001/XMLSchema#string

Prashant Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM.

Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients.

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential

Ectodomain shedding and remnant peptide signalling of EGFRs and their ligands.

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

Origins of Bladder Cancer.

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.

Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma.

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

The West Midlands Bladder Cancer Prognosis Programme: rationale and design.

P304

25244-25253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25397

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rik T Bryan

Maurice Zeegers

Kym Snell

P577

2018-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29861867

http://www.w3.org/2001/XMLSchema#string

P932

5982738

http://www.w3.org/2001/XMLSchema#string

P953

132590/